BioStock Studio: Rhovac’s CEO comments on the year-end report

Report this content

This morning Lund-based drug developer Rhovac released its year-end report. CEO Anders Månsson visited BioStock’s studio to tell us more about the company’s challenges and achievements during 2020 as well as the company’s development plan going forward. Månsson points out that the company has entered 2021 on solid ground and with strong finances, and is now continuing development and recruitment for the ongoing phase IIb study.

Watch the full interview at biostock.se:

https://www.biostock.se/en/biostock-studio-rhovacs-ceo-comments-on-the-year-end-report/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock Studio: Rhovac’s CEO comments on the year-end report
Tweet this